authors
-
Jerzy Świerż, Henryk Zieliński, Bronisław Stawarz
- Z Kliniki Urologii Centralnego Szpitala Klinicznego WAM w Warszawie
Kierownik Kliniki: prof. dr hab. med. S. Stawarz
keywords
-
Genitourinary tract neoplasms pulmonary metastases
summary
- 54 patients were treated for malignant neoplasms of the genitourinary system organs
- in whom pulmonary metastases were also diagnosed. In 16 (30%) patients pulmonary
- metastatic foci were diagnosed as early as the diagnosis of the neoplastic disease. In 6
- 11%) patients metastases appeared 2-3 months after the diagnosis and in 32 (59%
- patients metastatic lesions in the lungs appeared more then 6 months after the first
- diagnosis. 14% of patients were found to have pulmonary lesions of the lymphangitis
- carcinomatosa type. The tumour giving pulmonary metastases most often was kidney
- carcinoma (32 patients - 59%).
references
- [1] Anyanwu, E., Krysa, S., Buelzebruck, H., Vogt-Moykopf, /.: Pulmonary metasta-
- sectomy as secondary treatment for testicular tumors. Ann. Thorac. Surg. (1994),
- 5, 1222.
- [2] Boaziz, C.: Metastasis ofrenal cancer. Ann. Urol. Paris. 1991,6-7,275.
- [3] Brandys, A., Pawlicki, M.: Ocena skuteczności paliatywnego leczenia raka nerki.
- Urol. Pol. (1994), 1-2, 38.
- [4] Cerfolio, R., Allen, M., Deschamps, C, Daly, R., Wallńschs, S., Trostek, V: Pulmona-
- ry resection of metastatic renal cell carcinoma. Ann. Thorac. Surg. (1994), 2,339.
- [5] Fidler, J., Radinsky, R.: Genetic control of cancer. Metastasis. J. Natl. Cancer. Inst.
- (1990), 82, 166.
- [6] Gore, M., Galligioni, E., Keen, C, Sorio, R., Loriawc, E.: The treatment of metastatic
- renal cell carcinoma by continuous intravenous infusion of recombinant interleu-
- kin-2. Eur. J. Cancer (1994), 3,329.
- [7] Grandos, E., Hocsman, H., Mallo, N., Santaularia, J.: Multiple organ metastasis
- following nephrectomy for renal carcinoma. Arch. Esp. Urol. (1992), 45,260.
- [8] Haarstad, H., Jacobsen, A., Schjolseth, S., Risberg, T., Fossa, S.: Interferon-alpha, 5-
- FU and prednisone in metastatic renal cell carcinoma: a phase II study. Ann.
- Oncol. (1994), 3, 245.
- [9] Hanson, R, Belitsky, R, Miliard, O., Lannon, S.: Prognostic factors in metastatic
- nonseminomatous germ cell tumours. Can. J. Surg. (1993), 6,537.
- [10] Kuczyk, M, Bokemeyer, C, Thon, W, Serth, J., Allhoff, E., Jonas, U.: Metastatic
- adult teratoma of the testis. Possibilities of chemotherapy and surgical treatment.
- Urologe-A. (1994), 2,149.
- [11] Negrier, S., Mercatello, A., Coronel, B., Lanier, E, Merrouche Y, Bret, M., Blay, /.,
- Lasset, C, Thiesse, R, Came, C.: Treatment with cytokines of metastatic kidney
- cancer: the Lyon experience. Bull. Cancer Paris 1993,7,601.
- [12] Neri, B., Fiorelli, C, Moroni, E, Nicita, G, Paoletti, M., Ponchietti, R., Raugei, A.,
- Santoni, G, Trippitelli, A.,Grechi, G.: Modulation of human lymphoblastoid inter-
- feron activity by melatonin in metastatic renal cell carcinoma. A phase II study.
- Cancer (1994), 12, 3015.
- [13] Olivarez, D., Ulbright, T, DeRiese, W, Foster, R., Reister, T., Einhorn, L., Sledge, G.:
- Neovascularization in clinical stage A testicular germ cell tumor: prediction of
- metastatic disease. Cancer. Res. (1994),10,2800.
- [14] Sengelov, L., Kamby, C, Schou, G, von-der-Maase, H.: Prognostic factors and
- significance of chemotherapy in patients with recurrent or metastatic transitional
- cell cancer of the urinary tract. Cancer (1994), 1,123.
- [15] Świerż, /., Poznański, J., Stawarz, B.: Przerzut raka prącia do serca u 20-letniego
- chorego. Wiad. Lek. (1992), 7-8,314.
- [16] Świerż, J., Stawarz, B.: Przerzuty do płuc jako pierwszy objaw u chorych na raka
- jądra. Urol. Pol. (1993), 46,89.
- [17] Tongaonkar, H., Kulkami, J., Kamat, M.: Solitary metastases from renal cell carci-
- noma: a review. J. Surg. Oncol. (1992), 1,45.
- [18] Toth, L., Bodrogi, I., Baki, M., Bak, M., Besznyak: Thoracic surgery of testicular
- cancer patients Eur. J. Surg. Oncol. (1993), 6,609.
- [19] Yuoristo, M., Jantunen, I., Pyrhonen, S., Muhonen, T., Kellokumpu, E: A Combina-
- tion of subcutaneous recombinant interleukin 2 and recombinant interferon alpha
- in the treatment of advanced renal cell carcinoma or melanoma. Eur. J. Cancer.
- (1994), 4, 530.
- [20] Zanoni, E, Piva, L., Milani, A., Sahioni, R.: Chemotherapy of urologic metastases.
- Arch. Ital. Urol. Nefrol. Androl. (1992), 1,37.
|